Cytophage Technologies Ltd.
CPTCF
$0.19
$0.000.00%
OTC PK
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -15.32% | -23.70% | |||
| Depreciation & Amortization | 2.84% | -4.16% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -12.85% | -22.22% | |||
| Operating Income | 12.85% | 22.22% | |||
| Income Before Tax | 12.35% | 71.32% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 12.35% | 71.32% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 12.35% | 71.32% | |||
| EBIT | 12.85% | 22.22% | |||
| EBITDA | 16.30% | 23.74% | |||
| EPS Basic | 12.43% | 73.51% | |||
| Normalized Basic EPS | 12.26% | 28.38% | |||
| EPS Diluted | 12.43% | 74.70% | |||
| Normalized Diluted EPS | 12.26% | 28.38% | |||
| Average Basic Shares Outstanding | 0.14% | 7.99% | |||
| Average Diluted Shares Outstanding | 0.14% | 7.99% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||